Tallahassee Memorial Hospital

Tallahassee, Florida 32308-5054

2 studies enrolling now · 68 studies all time

What they study most

Acute Coronary Syndrome, Acute Pulmonary Embolism, Adenocarcinoma, Anal Cancer, Arrhythmia, Atherosclerosis, Atrial Fibrillation, Atrial Flutter, Bicuspid Aortic Valve, Bile Duct Cancer, Bladder Cancer, Bleeding

Studies at this site

• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• Integrated Cancer Repository for Cancer Research — Recruiting now
• SYMPHONY-PE Study for Treatment of Pulmonary Embolism — Completed
• CHAMPION-AF Clinical Trial — Running, not enrolling
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Running, not enrolling
• ADVENT Post Approval Study — Running, not enrolling
• A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) — Running, not enrolling
• A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency — Completed
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection — Completed
• Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study — Running, not enrolling
• Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System — Completed
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
• The PEERLESS Study — Completed
• Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR — Completed
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
• LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) — Completed
• Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
• Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS — Status unconfirmed
• RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) — Completed
• RESOLUTE ONYX Post-Approval Study — Completed
• A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) — Completed
• Absorb IV Randomized Controlled Trial — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) — Completed
• Coping in Heart Failure Partnership Intervention — Completed
• Online Mindfulness-based Intervention to Prevent Chronic Pain — Completed
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology — Completed
• Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism — Completed
• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial — Completed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads — Completed
• Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer — Completed
• EVOLVE Short DAPT Study — Completed
• Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer — Completed
• PLATINUM Diversity — Completed
• Longitudinal Surveillance Registry (LSR) of ACUITY Spiral — Stopped early
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed